Corporate Profile

We are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

More
ANAB (Common Stock) $78.18 Stock is Down 1.05 (1.33%)11/22/17 4:00 p.m. ET
Stock chart for: ANAB.O.  Currently trading at $78.18 with a 52 week high of $79.45 and a 52 week low of $15.17.
Data provided by Nasdaq. Minimum 15 minutes delayed.




  |   |   |   |   |